A world-first facility opening in Christchurch could bring cutting-edge cancer treatment closer to home for Kiwi patients.

BioOra will manufacture CAR-T therapies at the central site, using patients' own genetically modified cells to fight cancer.

It could eventually treat 150 patients a year, reducing the need for overseas treatment, which can cost more than a million dollars.

Chief Executive John Robson told Mike Hosking the facility has sophisticated set of laboratories.

He says there's six in total, with four of them being 'super clean rooms,' where staff will be genetically modifying cells for patients.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

Our gaming sector is continuing to flourish, and one game developer believes there's no reason it can't keep growing with investment.

New Zealand First wants to lift funding for the Centre of Digital Excellence by 2028 and to improve the studio rebate.

That includes increasing the claimable amount from $3 million to $10 million.

RocketWerkz Games Chief Operating Officer Stephen Knightly told Mike Hosking it's closing the gap that Australia continues to have over our industry.

He says Australia is fighting for tech jobs and creative jobs and believes New Zealand's naive if it doesn't fight back.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

The Speaker of the House says there was no choice but to act as threats against MPs see a massive increase.

RNZ reports the Parliament Security Information, Risk and Advisory Service deployed 81 times after handling 216 requests for advice or support between September 28 and October 18.

Parliamentary Service says its security offering has grown and it's working closely with Police.

Speaker Gerry Brownlee told Mike Hosking there's been a particular increase in threats towards women.

He says the nature of threats have also changed from being a bit of personal abuse about appearance to serious threats of physical violence.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.